| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34099515 |
| PharmacoGx | BRD-K34099515 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDE4D | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | OSGIN1 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.007 |
| mRNA | FBXO22 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | C15orf61 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.007 |
| mRNA | GGT1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.007 |
| mRNA | NUP210 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.007 |
| mRNA | PARG | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | GALNT5 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.007 |
| mRNA | DNM1 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
